Market Research Logo

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Norway

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Norway

Summary

Norway is a mature healthcare market, with a strong focus on healthcare spending.Norway spends 10.5% of its GDP on healthcare that is the third highest in the world. The health system is mostly publicly financed, primarily through a national insurance tax.The national insurance, or social security, is a collective compulsory insurance plan for Norwegian citizens.The healthcare sector employs about 454,000 people with around 166,000 in the government sector and 76,000 in the private sector.

Value of the Norwegian pharmaceutical market increased from $2.18 billion in 2010 to $2.37 billion in 2017, at a compound annual growth rate (CAGR) of 1.2%. The Over-The Counter (OTC) market was $770m in 2012 and increased to $1,040m in 2017 at a CAGR of 7.8%.The medical device market increased from $1.31 billion in 2010 to $1.71 billion in 2017. The market is expected to grow at a CAGR of 4.9% from $1.79 billion in 2018 to $2.17 billion in 2022.

In 2017, there were about 1,951,522 patients at general hospitals with 534,103 in-patients, 273,596 day-care patients and 1,788,371 out-patients.The increasing elderly population and high investment in R&D expenditure are expected to drive the growth of healthcare market. However, generic substitution and parallel imports pose as a barrier for the pharmaceutical companies

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Norway, forms an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Norway. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Norway. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Norway, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Merck, Leo Pharma, Bayer and Vistin Pharma) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Philips Healthcare, Roche Diagnostics, Essilor and Photocure)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Norway
  • Porter’s five forces analysis for pharmaceutical and medical devices market of Norway
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Norwegian healthcare market
Reasons to buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the Norwegian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Norwegian healthcare market


Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix
List of Tables
Table 1: OTC Market, Norway, Top Product Sales ($m), 2017
Table 2: Pharmaceutical Market, Norway, Pharmaceutical Sales by Therapeutic Area ($m), 2017
Table 3: IVD Devices Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2017
Table 4: Ophthalmic Devices Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2015
Table 5: Orthopedic Devices Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2016
Table 6: Healthcare IT Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2016
Table 7: Cardiovascular Devices Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2017
Table 8: Reimbursement Categories and Rates, Norway, 2015
Table 9: National Insurance Contribution Rates, Norway, 2016
Table 10: Pricing Procedures, Norway, 2015
Table 11: Market Authorization Fees, Norway, 2018
Table 12: Types of Import Authorizations for Clinical Studies, Norway, 2017
Table 13: Patent Fees, Norway, 2017
Table 14: Trademark Fees, Norway, 2017
Table 15: Clinical Trial Regulation, Norway, 2017
Table 16: Advertising Regulations, Norway, 2017
Table 17: Labeling and Packaging Regulations, Norway, 2017
Table 18: Nordic Package
Table 19: Trade Fairs, Norway, 2018-2019
List of Figures
Figure 1: Pharmaceutical Market, Norway, Revenue ($bn), 2010-2017
Figure 2: Medical Device Market, Norway, Revenue ($bn), 2010-2017
Figure 3: Country Profile, Norway, 2017
Figure 4: Pharmaceutical Market, Norway, Revenue ($bn), 2010-2017
Figure 5: Pharmaceutical Market, Norway, Revenue Forecast ($bn), 2018-2022
Figure 6: Pharmaceutical Exports ($bn), Norway, 2010-2016
Figure 7: Top Export Partners, Norway, 2016
Figure 8: Pharmaceutical Imports ($bn), Norway, 2010-2016
Figure 9: Top Import Partners, Norway, 2016
Figure 10: Pharmaceutical Value Chain, Norway, 2017
Figure 11: Pharmaceutical Market, Norway, Pharmaceutical Sales by Therapeutic Area($m), 2017
Figure 12: Pharmaceutical Market, Norway, Major Players
Figure 13: Medical Device Market, Norway, Revenue ($bn), 2010-2017
Figure 14: Medical Device Market, Norway, Revenue Forecast ($bn), 2018-2022
Figure 15: Medical Device Market, Norway, Revenue by Segment ($m), 2017
Figure 16: IVD Devices Market, Norway, Revenue ($m), 2010-2017
Figure 17: IVD Devices Market, Norway, Market Share of Major Players (%), 2017
Figure 18: Ophthalmic Devices Market, Norway, Revenue ($m), 2010-2017
Figure 19: Ophthalmic Devices Market, Norway, Market Share of Major Players (%), 2015
Figure 20: Orthopedic Devices Market, Norway, Revenue ($m), 2010-2017
Figure 21: Orthopedic Devices Market, Norway, Market Share of Major Players (%), 2016
Figure 22: Healthcare IT Market, Norway, Revenue ($m), 2010-2017
Figure 23: Healthcare IT Market, Norway, Market Share of Major Players (%), 2016
Figure 24: Cardiovascular Devices Market, Norway, Revenue ($m), 2010-2017
Figure 25: Cardiovascular Devices Market, Norway, Market Share of Major Companies (%), 2017
Figure 26: Diagnostic Market, Norway, Revenue ($m), 2010-2017
Figure 27: Diagnostic Market, Norway, Revenue ($m), 2018-2022
Figure 28: Medical Device Market, Norway, Revenue ($bn) of Major Companies, 2016
Figure 29: Deal Value and Deal Count, Pharmaceutical Market, Norway, 2017-2018
Figure 30: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Norway, 2017-2018
Figure 31: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Norway, 2017-2018
Figure 32: Pharmaceutical Market, Norway, Top Five Therapy Areas by Deal Value ($m), 2017-2018
Figure 33: Pharmaceutical Market, Norway, Top Five Therapy Areas by Deal Number, 2017-2018
Figure 34: Pharmaceutical Market, Norway, M&A Deals by Therapy Area, 2017-2018
Figure 35: Pharmaceutical Market, Norway, Venture Financing Deals by Therapy Area, 2017-2018
Figure 36: Medical Device Market Deals by Deal Value ($m), Norway, 2017-2018
Figure 37: Medical Device Market Deals by Deal Count, Norway, 2017-2018
Figure 38: Medical Device Market Deals Share by Deal Count, Norway, 2017-2018
Figure 39: Medical Device Market Deals Share (by deal value), Norway, 2017-2018
Figure 40: Medical Device, Norway, Top Therapy Area by Deal Value, 2017-2018
Figure 41: Medical Devices, Norway, Top Therapy Area by Deal Number, 2017-2018
Figure 42: Medical Devices, Norway, M&A Deals by Therapy Area, 2017-2018
Figure 43: Medical Devices, Norway, Venture Financing Deals by Therapy Area, 2017-2018
Figure 44: Medical Devices, Norway, Private Equity Deals by Therapy Area, 2017-2018
Figure 45: Organization of the Health System, Norway, 2016
Figure 46: Decision Making Process, Norway, 2015
Figure 47: Out-of-Pocket Expenditure (% of total expenditure on health), Norway, 2010-2016
Figure 48: Annual Rate of Change (%), Health Price Index, Norway, 2010-2017
Figure 49: Norway Medicines Agency, Organization Chart, 2017
Figure 50: National Procedure, Norway, 2017
Figure 51: Centralized Procedure, Norway, 2017
Figure 52: Decentralized Procedure, Norway, 2017
Figure 53: Medical Device Market Deals Share (by deal value), Norway, 2017-2018
Figure 54: Medical Device, Norway, Top Therapy Area by Deal Value, 2017-2018
Figure 55: Mutual Recognition Procedure, Norway, 2017
Figure 56: Conformity Assessment of Class I Medical Devices, EU, 2017
Figure 57: Conformity Assessment of Class IIa Medical Devices, EU, 2017
Figure 58: Conformity Assessment of Class IIb Medical Devices, EU, 2017
Figure 59: Conformity Assessment of Class III Medical Devices, EU, 2017
Figure 60: European Patent Approval Process, EU, 2017
Figure 61: Number of Hospitals, Norway,2010-2017
Figure 62: Diagnostic Equipment (per million population), Norway,2010-2017
Figure 63: Hospital Beds (per 1,000 population), Norway, 2010-2017
Figure 64: Curative Care Hospital Beds (per 1,000 population), Norway, 2010-2017
Figure 65: Psychiatric Hospital Beds (per 1,000 population), Norway, 2010-2017
Figure 66: Life Expectancy (in years), Norway, 2010-2017
Figure 67: Immunization Rate (%), Norway, 2010-2017
Figure 68: PM2.5 (μg per m3), Norway, 2010-2017
Figure 69: CO2 Emissions (metric tons per capita), Norway, 2010-2017
Figure 70: Physicians (per 1,000 population), Norway, 2010-2017
Figure 71: Nurses (per 1,000 population), Norway, 2010-2017
Figure 72: Dentists, (per 1,000 population), Norway, 2010-2017
Figure 73: Pharmacists, (per 1,000 population), Norway, 2010-2017
Figure 74: Major Causes of Mortality (Number of Deaths, ‘000), Norway, 2015
Figure 75: Major Causes of Male Mortality (Number of Deaths, ‘000), Norway, 2015
Figure 76: Major Causes of Female Mortality (Number of Deaths, ‘000), Norway, 2015
Figure 77: Disability-Adjusted Life Years by Major Disease (‘000), Norway, 2015
Figure 78: Healthcare Expenditure as Percentage of GDP (%), Norway, 2010-2017
Figure 79: Public-Private Share (%), Norway, 2010-2017
Figure 80: Major Components of Healthcare Expenditure(%), Norway, 2016
Figure 81: Spending in Pharmaceutical and Healthcare R&D ($m), Norway, 2010-2015
Figure 82: Opportunities & Challenges, Norway

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report